Shao Wei-Hua, Wang Cheng-Yu, Wang Lei-Yun, Xiao Fan, Xiao De-Sheng, Yang Hao, Long Xue-Ying, Zhang Le, Luo Heng-Gui, Yin Ji-Ye, Wu Wei
Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078, People's Republic of China.
Institute of Clinical Pharmacology, Central South University; Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, People's Republic of China.
Cancer Manag Res. 2020 Feb 27;12:1469-1482. doi: 10.2147/CMAR.S222572. eCollection 2020.
In order to clarify which variants of the MMR gene could provide current "healthy" members in affected families a more accurate risk assessment or predictive testing.
One family, which meets the criteria according to both Amsterdam I/II and Bethesda guidelines, is reported in this study. The proband and some relatives of the patient have been investigated for whole genome sequencing, microsatellite instability, immunohistochemical MMR protein staining and verified by Sanger sequencing.
A heterozygous insertion of uncertain significance (c.420dup, p.Met141Tyrfs) in MSH2 gene was found in proband (III-16) and part of His relatives. The variant was associated with a lack of expression of MSH2 protein (MMR deficient) and high microsatellite instability analysis (MSI) status in tumor tissues of LS patients. In addition, we found that the variant could affect the expression of MSH2 and the response to chemotherapy drugs in vitro.
We identified an insertion mutation (rs1114167810, c.420dup, p.Met141Tyrfs) in MSH2 in LS using whole genome-wide sequencing (WGS). We further confirmed that this mutation plays an important role in LS patients of this pedigree based on in vivo and vitro study.
为了明确错配修复(MMR)基因的哪些变异能够为患病家族中目前“健康”的成员提供更准确的风险评估或预测性检测。
本研究报告了一个符合阿姆斯特丹I/II和贝塞斯达指南标准的家族。对先证者及该患者的一些亲属进行了全基因组测序、微卫星不稳定性检测、MMR蛋白免疫组化染色,并通过桑格测序进行验证。
在先证者(III-16)及其部分亲属中发现了MSH2基因的一个意义未明的杂合插入突变(c.420dup,p.Met141Tyrfs)。该变异与林奇综合征(LS)患者肿瘤组织中MSH2蛋白表达缺失(MMR缺陷)及高微卫星不稳定性分析(MSI)状态相关。此外,我们发现该变异在体外可影响MSH2的表达及对化疗药物的反应。
我们通过全基因组测序(WGS)在LS患者中鉴定出MSH2基因的一个插入突变(rs1114167810,c.420dup,p.Met141Tyrfs)。基于体内和体外研究,我们进一步证实该突变在这个家系的LS患者中起重要作用。